Hims & Hers Health, Inc.

NYQ: HIMS

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Hims & Hers Health, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get HIMS Z-Score →

About Hims & Hers Health, Inc.

Healthcare Drug Manufacturers - Specialty & Generic

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

📊 Fundamental Analysis

Hims & Hers Health, Inc. demonstrates a profit margin of 5.5%, which is below the sector average, suggesting competitive pressure.

The company recently reported 28.4% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is 25.2%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $19.43, HIMS currently trades near the bottom of its 52-week range (10%), indicating potential value or weakness (Range: $13.74 - $70.43).

💰 Valuation Insight

HIMS trades at a 52.4% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak

🔴 Debt/Equity Elevated

✅ Revenue Growth Excellent

⚠️ Return on Equity Moderate

🔴 Beta (Risk) High Volatility

Key Financials

Market Cap

$4.43B

Trailing P/E

38.10

Forward P/E

13.69

Beta (5Y)

2.31

52W High

$70.43

52W Low

$13.74

Avg Volume

34.91M

Day High

Day Low

Get HIMS Z-Score on Dashboard 🚀